How drug development works
A new medicine typically spends more than a decade moving from a laboratory idea to an approved product, and most candidates never make it. These guides explain each stage, the historical odds of success, and how to read the clinical evidence behind every drug.
How drug development works
From a laboratory idea to an approved medicine.
How Are New Drugs Discovered?
Drug discovery runs from choosing a biological target, through finding and refining a molecule that acts on it, to the preclinical studies needed before testing in people.
What Are the Phases of Clinical Trials?
Clinical trials move through Phase 1, 2, and 3 before approval, and Phase 4 after it. Each phase asks a different question with a different number of participants.
How Long Does It Take to Develop a Drug?
A new drug typically takes 10 to 15 years from discovery to approval. Clinical development alone averages about a decade, and timelines vary widely by disease and drug type.
How Does the FDA Approve New Drugs?
The FDA approves a new drug when the sponsor's application shows substantial evidence that it works and that its benefits outweigh its risks for the intended use. Here is how the review works.
Why Do Experimental Drugs Fail?
About 90% of drugs that enter clinical trials are never approved. Most fail because they do not work well enough in patients or because their side effects are unacceptable.
Success rates and probabilities
How often drugs succeed at each stage, and how the odds are calculated.
What Percentage of Drugs Pass Phase 1?
About half of drugs that enter Phase 1 trials advance to Phase 2. The rate varies by disease area and by how the data are counted, and passing Phase 1 says little about whether a drug works.
What Percentage of Phase 2 Drugs Get Approved?
Roughly 15% of drugs in Phase 2 go on to FDA approval, based on industry data from 2011 to 2020. The odds range from about 10% to more than 30% depending on the disease area and whether patients are selected with biomarkers.
What Are the Chances of FDA Approval After Phase 2?
A typical drug that completes Phase 2 has historically had well under even odds of approval. For an individual drug, the real question is which factors move its odds above or below that average.
Why Do Phase 3 Clinical Trials Fail?
Roughly 4 in 10 Phase 3 programs fail to reach a marketing application. Most fail because the drug's benefit doesn't hold up in a larger, more rigorous trial, often because the Phase 2 result was overstated.
How Are Drug Approval Probabilities Calculated?
Drug approval probabilities are usually built from historical phase transition rates, multiplied together. How programs are counted changes the answer, and estimates for individual drugs require models that account for the evidence.
How We Show Drug Approval Odds
Our methodology: where the approval odds on Spectral Genomics drug profiles come from, rates by therapeutic area, and the rules we follow.
Reading clinical evidence
The concepts you need to judge a trial result for yourself.
What Is a Primary Clinical Trial Endpoint?
A primary endpoint is the main outcome a clinical trial is designed to measure, chosen before the trial starts. Whether it is met usually decides whether the trial counts as a success.
What Is Statistical Significance in Clinical Trials?
A result is statistically significant when it would be unlikely to arise by chance if the drug had no effect, usually judged by a p-value below 0.05. Significance does not tell you how large or important the effect is.
What Is an Independent Clinical Trial Replication?
A replication is a separate trial that tests the same question and finds a consistent result. Independent replication is one of the strongest protections against results that turn out to be flukes.
What Is a Placebo-Controlled Trial?
In a placebo-controlled trial, one group receives the experimental drug and another receives an inactive look-alike, usually without anyone knowing who got which. It is the clearest way to show that a drug, and not something else, caused an effect.
How Do Scientists Evaluate Drug Safety?
Drug safety is assessed in stages, from animal toxicology to clinical trials to monitoring after approval. Because trials are limited in size, rare side effects are often found only once a drug is widely used.
Genomics and precision medicine
For the science behind new drug targets, see our biotechnology guides, including genomics, precision medicine, and CRISPR gene editing.